Xerium Technologies, Inc. (NYSE:XRM), a leading global
manufacturer of industrial textiles and roll covers used primarily
in the paper production process, today reported results for its
third quarter ended September 30, 2010.
“We continue to grow our business and expand our place in the
market by developing products that satisfy our customers’ demand
for value in their challenging operating environment,” said Stephen
R. Light, President, Chief Executive Officer and Chairman. “As the
paper market continues to show signs of health, we are encouraged
that more manufacturers are looking for ways to further boost
efficiencies, reduce materials waste and keep inventories low. We
are working very closely with our customers to be the supplier of
choice by providing better value in order to increase market
penetration as we continue to roll out high-ROI textiles and rolls
products.”
THIRD QUARTER FINANCIAL
HIGHLIGHTS
- Net sales for the 2010 third quarter
were $135.9 million, a 4.3% increase from net sales for the 2009
third quarter of $130.3 million. Excluding currency effects shown
in the table below, third quarter 2010 net sales increased 7.0%
from the third quarter of 2009, with increases of 7.3% and 6.3% in
the clothing and roll covers segments, respectively. See “Segment
Information” below.
- Gross margins increased to $52.6
million for the third quarter of 2010 from $48.8 million for the
third quarter of 2009, which represented a 7.8% increase. The
Company’s operating expenses (selling, general and administrative,
restructuring and impairments and research and development
expenses) for the third quarter of 2010 increased by $3.0 million
to $39.9 million, an 8.1% increase from operating expenses of $36.9
million in the 2009 third quarter. The increase is primarily the
result of the following:
- Restructuring and impairment expenses
increased by $1.5 million in the third quarter of 2010 as compared
to the third quarter of 2009. The increase is primarily a result of
a $2.1 million asset impairment in the third quarter of 2010
related to the Company’s mothballed Vietnam facility.
- Selling expenses increased by $1.0
million, primarily as a result of higher sales commissions and
related expenses from increased sales volumes in the third quarter
of 2010 as compared to third quarter of 2009.
- General and administrative expenses
increased by $0.3 million in the 2010 third quarter as compared to
the 2009 third quarter. The increase is primarily the result of (i)
increased stock-based compensation and management incentive
compensation of $1.5 million and (ii) a $1.4 million increase in
provisions for doubtful accounts, primarily due to the absence in
the third quarter of 2010 of a $1.6 million decrease recorded in
the third quarter of 2009. These increases were partially offset by
the absence in the third quarter of 2010 of $2.7 million of bank
and related fees that were incurred in the third quarter of 2009
relating to initiatives undertaken to resolve the Company’s credit
issues.
- Net loss for the third quarter of 2010
was $3.7 million or $0.24 per diluted share, compared to a net loss
of $7.4 million or $3.02 per diluted share for the third quarter of
2009. As part of its recent plan of reorganization, the Company
implemented a 20-to-1 reverse split of its common stock and
accordingly, the effect of the split has been reflected
retroactively for all periods presented.
- Adjusted EBITDA (as defined by the
Company’s existing credit facility which was entered into on May
25, 2010) was $29.1 million for the third quarter of 2010. The
definition of Adjusted EBITDA in 2010 is different than the
definition in the Company’s prepetition credit facility which was
used for 2009. Had the definition of Adjusted EBITDA for 2010 been
in place for 2009, Adjusted EBITDA for the third quarter of 2009
would have been $27.9 million. See “Non-GAAP Financial Measures”
below.
- Cash on hand at September 30, 2010 was
$32.5 million, compared to $33.3 million at June 30, 2010 and $21.8
million at September 30, 2009.
- Total bank debt at September 30, 2010
was $486.2 million, an increase of $12.4 million from $473.8
million at June 30, 2010, primarily as a result of unfavorable
currency effects of $15.6 million, partially offset by principal
payments of $3.2 million.
SEGMENT INFORMATION
The following table presents net sales for the third quarter of
2010 and 2009 by segment and the effect of currency on third
quarter 2010 net sales:
(dollars in millions):
Net SalesThree Months
EndedSeptember 30,
Percent increase innet sales
from Q3 2009to Q3 2010
2010
2009
Increasein net salesfrom
Q3 2009to Q3 2010
Decreasein Q3 2010net
sales dueto currency
Total
Excludingcurrencyeffects
Clothing $
90.3
$
86.0
$
4.3
($2.0
)
5.0
%
7.3
% Roll Covers 45.6 44.3 1.3
(1.5
)
2.9
%
6.3
% Total $
135.9
$
130.3
$
5.6
($3.5
)
4.3
%
7.0
%
CONFERENCE CALL
The Company plans to hold a conference call to discuss these
results tomorrow morning:
Date: Friday, November 5, 2010 Start Time: 9:00 a.m. Eastern
Time Domestic Dial-In: +1-800-901-5217 International Dial-In:
+1-617-786-2964 Passcode: 92087690 Webcast & Slide
Presentation:
www.xerium.com/investorrelations
To participate on the call, please dial in at least 10 minutes
prior to the scheduled start. A live audio webcast and replay of
the call, in addition to a slide presentation, may be found in the
investor relations section of the company’s website at
www.xerium.com.
NON-GAAP FINANCIAL
MEASURES
This press release includes measures of performance that differ
from the Company’s financial results as reported under generally
accepted accounting principles (“GAAP”). The Company uses
supplementary non-GAAP measures, including EBITDA and Adjusted
EBITDA, to assist in evaluating financial performance, specifically
in evaluating the ability to service indebtedness and to fund
ongoing capital expenditures. The Company’s credit facility
includes covenants based upon Adjusted EBITDA. If Adjusted EBITDA
declines below certain levels, the Company could go into default
under the credit facility or be required to prepay the credit
facility. Neither Adjusted EBITDA nor EBITDA should be considered
in isolation or as a substitute for income (loss) from operations
(as determined in accordance with GAAP).
For additional information regarding non-GAAP financial measures
and a reconciliation of such measures to the most comparable
financial measures under GAAP, please see below. The information in
this press release should be read in conjunction with the financial
statements and footnotes contained in our documents to be filed
with the Securities and Exchange Commission.
About Xerium Technologies
Xerium Technologies, Inc. (NYSE: XRM) is a leading global
manufacturer and supplier of two types of consumable products used
primarily in the production of paper: clothing and roll covers. The
Company, which operates around the world under a variety of brand
names, utilizes a broad portfolio of patented and proprietary
technologies to provide customers with tailored solutions and
products integral to production, all designed to optimize
performance and reduce operational costs. With 32 manufacturing
facilities in 14 countries around the world, Xerium has
approximately 3,400 employees.
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements involving
risks and uncertainties, both known and unknown, that may cause
actual results to differ materially from those indicated. These
risks and uncertainties include the following items: (1) our
revenues and profitability could be adversely affected by
fluctuations in interest rates and currency exchange rates; (2) a
sustained downturn in the paper industry, compounded by uncertainty
in global economic conditions, could adversely affect our revenues
and profitability; (3) market improvement in our industry may occur
more slowly than we anticipate or not at all; (4) variations in
demand for our products, including our new products, could
negatively affect our revenues and profitability; (5) our
manufacturing facilities may be required to operate at or near
capacity, which could negatively affect our production facilities,
customer order lead time, product quality and labor relations; (6)
our plans to develop and market new products, enhance operational
efficiencies, and reduce costs may not be successful; and (7) the
other risks and uncertainties discussed elsewhere in this press
release, our Form 10-Q for the quarter ended June 30, 2010, and our
subsequent SEC filings. If any of these risks or uncertainties
materialize, or if our underlying assumptions prove to be
incorrect, actual results may vary significantly from what we
projected. Any forward-looking statement in this press release
reflects our current views with respect to future events. We assume
no obligation to publicly update or revise these forward-looking
statements for any reason, whether as a result of new information,
future events, or otherwise. As discussed above, we are subject to
substantial risks and uncertainties related to current economic
conditions, and we encourage investors to refer to our SEC filings
for additional information. Copies of these filings are available
from the SEC and in the investor relations section of our website
at www.xerium.com.
Xerium Technologies,
Inc.Condensed Consolidated Statements of
Operations—(Unaudited)(dollars in thousands, except per
share data)
Three Months EndedSeptember
30,
Nine Months EndedSeptember 30, 2010
2009 2010 2009 Net sales $
135,899 $ 130,308 $ 403,741 $ 367,654 Costs and expenses: Cost of
products sold 83,258 81,520 247,671 228,956 Selling 18,043 16,991
53,986 49,574 General and administrative 15,652 15,428 60,097
35,100 Restructuring and impairments 3,322 1,754 7,433 2,894
Research and development 2,887 2,708
8,707 8,168 123,162
118,401 377,894 324,692
Income from operations 12,737 11,907 25,847 42,962 Interest expense
(12,330 ) (16,651 ) (45,366 ) (48,899 ) Interest income 310 226 837
947 Foreign exchange gain (loss) 744 561
736 (225 ) Income (loss) before
reorganization items and provision for income taxes 1,461 (3,957 )
(17,946 ) (5,215 ) Reorganization items 799 — 44,374 — Provision
for income taxes 4,318 3,424
11,504 10,013 Net loss $ (3,656 ) $ (7,381 ) $
(73,824 ) $ (15,228 ) Net loss per share: Basic and diluted $ (0.24
) $ (3.02 ) $ (8.84 ) $ (6.23 ) Shares used in computing net loss
per share: Basic and diluted 14,970,050
2,444,149 8,350,635 2,444,913
Condensed Consolidated Selected
Financial Data
(in thousands)
Nine Months EndedSeptember
30,
2010
2009
Balance sheet data (at end of period): Cash and cash
equivalents $ 32,487 $ 21,816 Total assets 694,865 784,456 Senior
debt 479,887 591,471 Total debt 486,221 628,554 Total stockholders’
equity (deficit) 19,683 (23,456 )
Cash flow data: Net
cash provided by operating activities $ 3,465 $ 3,789 Net cash used
in investing activities (29,639 ) (8,659 ) Net cash provided by
(used in) financing activities 35,534 (9,314 )
Other
financial data: Depreciation and amortization $ 30,763 $ 30,769
Capital expenditures 14,405 13,970
NON-GAAP LIQUIDITY MEASURES
The Company uses EBITDA and Adjusted EBITDA as supplementary
non-GAAP liquidity measures to assist in evaluating its liquidity
and financial performance, specifically its ability to service
indebtedness and to fund ongoing capital expenditures. The Amended
and Restated Credit Facility includes covenants based on Adjusted
EBITDA. If the Company’s Adjusted EBITDA declines below certain
levels, the Company will violate the covenants resulting in a
default condition under the credit facility or be required to
prepay the credit facility. Neither EBITDA nor Adjusted EBITDA
should be considered in isolation or as a substitute for income
(loss) from operations (as determined in accordance with GAAP).
EBITDA is defined as net income (loss) before interest expense,
income tax provision (benefit) and depreciation (including non-cash
impairment charges) and amortization.
Adjusted EBITDA is defined in the Amended and Restated Credit
Facility as the total of (A) Consolidated Net Income, as
defined below, plus (B), without duplication, to the extent that
any of the following were deducted in computing consolidated net
income: (i) provision for taxes based on income or profits,
(ii) consolidated interest expense, (iii) consolidated
depreciation and amortization expense, (iv) reserves for
inventory in connection with plant closures, (v) consolidated
operational restructuring costs, not to exceed $15 million in
fiscal year 2010, $6 million in fiscal year 2011, and $5 million in
any of the 2012, 2013, 2014 or 2015 fiscal years,
(vi) consolidated financial restructuring costs, not to exceed
$30 million for fiscal year 2010, (vii) non-cash charges or
gains resulting from the application of purchase accounting,
including push-down accounting, (viii) non-cash expenses
resulting from the granting of common stock, stock options,
restricted stock or restricted stock unit awards under equity
compensation programs solely with respect to common stock, and cash
expenses for compensation mandatorily applied to purchase common
stock, (ix) non-cash items related to a change in or adoption
of accounting policies, (x) expenses incurred as a result of
the repurchase, redemption or retention by the Company of common
stock earned under equity compensation programs solely in order to
make withholding tax payments, and (xi) amortization or
write-offs of deferred financing costs, minus (C) without
duplication, to the extent any of the following were included in
computing consolidated net income for such period,
(i) non-cash gains with respect to the items described in
clauses (vii), (viii) and (ix) of clause (B) above
and (ii) provisions for tax benefits based on income or
profits. Adjusted EBITDA, as defined in the credit facility and
calculated below, may not be comparable to similarly titled
measurements used by other companies.
Consolidated Net Income is defined as net income
(loss) determined on a consolidated basis in accordance with
GAAP; provided, however, that the following, without duplication,
shall be excluded in determining Consolidated Net Income:
(i) any net after-tax extraordinary or non-recurring gains,
losses or expenses (less all fees and expenses relating thereto),
(ii) the cumulative effect of changes in accounting
principles, (iii) any fees and expenses incurred during such period
in connection with the issuance or repayment of indebtedness, any
refinancing transaction or amendment or modification of any debt
instrument, in each case, as permitted under the Amended and
Restated Credit Facility and (iv) any gains resulting from the
returned surplus assets of any pension plan.
The following table provides a reconciliation from net loss,
which is the most directly comparable GAAP financial measure, to
EBITDA and Adjusted EBITDA. The three and nine months ended
September 30, 2010 are presented based on the Adjusted EBITDA
definitions in the Amended and Restated Credit Facility. The three
and nine months ended September 30, 2009 are presented based on the
Adjusted EBITDA definitions in effect under the credit agreement at
that time. Had the definitions in the Amended and Restated Credit
Facility been in place for 2009, Adjusted EBITDA for the three and
nine months ended September 30, 2009 would have increased by
$2,820,000 and $3,983,000 respectively, as per discussion in (A)
through (F) below.
Three Months EndedSeptember 30, (in
thousands) 2010 2009 Net loss $ (3,656 ) $
(7,381 ) Income tax provision 4,318 3,424 Interest expense, net
12,020 16,425 Depreciation and amortization 10,222
10,851
EBITDA 22,904 23,319
Change in fair value of interest rate swaps (A) — (859 )
Operational restructuring expenses 1,199 87 Inventory write-offs
under restructuring programs
—
104 Non-cash compensation and related expenses (B) 2,068 778
Financial restructuring costs (D) 799
—
Non-cash impairment charges (F) 2,123 1,667
Adjusted EBITDA $ 29,093
$ 25,096
Nine Months EndedSeptember
30,
2010 2009 Net loss $ (73,824 ) $ (15,228 ) Income tax
provision 11,504 10,013 Interest expense, net 44,529 47,952
Depreciation and amortization 30,763 30,769
EBITDA 12,972 73,506 Change in fair
value of interest rate swaps (A) — (1,654 ) Operational
restructuring expenses 4,562 1,227 Inventory write-offs under
restructuring programs — 349 Non-cash compensation and related
expenses (B) 5,498 1,824 Non-cash change in accounting method (C)
(1,400 ) — Financial restructuring costs (D) 25,613 — Non-cash
impairment charges (F) 2,871 1,667 Write-off of deferred financing
cost as “reorganization item” (E) 14,283 — Expenses incurred in
connection with indebtedness or refinancing transaction
14,400 —
Adjusted EBITDA
$ 78,799
$ 76,919
(A) The changes in the fair value of interest rate swaps is not
an adjustment under the definition of Adjusted EBITDA in the
Amended and Restated Credit Facility to arrive at Adjusted EBITDA
for periods beginning after the quarter ended December 31,
2009. For the three and nine months ended September 30, 2009, such
items were added back to (deducted from) EBITDA based upon the
terms of the pre-petition credit facility. Had the amended
definition been in place for all periods presented, Adjusted EBITDA
for the three and nine months ended September 30, 2009 would have
increased by $859 and $1,654, respectively.
(B) The nine months ended September 30, 2010 include an add-back
of $539 to EBITDA to arrive at Adjusted EBITDA related to shares of
common stock that were sold to Mr. Light on January 5,
2010 for this amount in reliance upon the exemption from
registration provided by Section 4(2) of the Securities Act of
1933, as amended. Had the amended definition been in place for all
periods presented, the three and nine months ended September 30,
2009 each would have been impacted by an add back of $0 and $94,
respectively.
(C) Changes in non-cash items related to a change in or adoption
of accounting policies, as defined in the Amended and Restated
Credit Facility, are added back to (deducted from) EBITDA to arrive
at Adjusted EBITDA for periods beginning after the quarter ended
December 31, 2009. For the three and nine months ended
September 30, 2009, such items were not added back to EBITDA based
upon the terms of the pre-petition credit facility. Had the amended
definition been in place for all periods presented, there would
have been no impact to Adjusted EBITDA for the three and nine
months ended September 30, 2009 as there were no charges or credits
recorded during those periods pertaining to changes in or adoption
of accounting policies.
(D) Financial restructuring costs that have been expensed to the
statement of operations are added back to EBITDA to arrive at
Adjusted EBITDA for periods beginning after the quarter ended
December 31, 2009. For the three and nine months ended
September 30, 2009, such items were not added back to EBITDA based
upon the terms of the pre-petition credit facility. Had the amended
definition been in place for all periods presented, the three and
nine months ended September 30, 2009 would have been impacted by an
add-back of $1,961 and $2,235, respectively.
(E) The write-off of deferred financing costs included in
reorganization items in the statement of operations is added back
to EBITDA to arrive at Adjusted EBITDA for periods beginning after
the quarter ended December 31, 2009. As of March 31,
2010, we were required to record such costs in “reorganization
items” as per ASC Topic 852, Reorganizations, as a result of our
filing voluntary petitions for relief under chapter 11 on
March 30, 2010. Prior to March 31, 2010, any write-offs
of deferred financing costs were charged to interest expense and
accordingly added back in the “interest expense, net” line item of
the Adjusted EBITDA reconciliation above. Accordingly the amended
definition has no impact on total Adjusted EBITDA for the three or
nine months ended September 30, 2009 because under both definitions
the write-off of deferred financing costs was allowed as an
add-back.
(F) In accordance with the definition of Adjusted EBITDA in the
Amended and Restated Credit Facility, non-cash impairment charges
resulting from application of Topic 350 and ASC Topic 360,
Property, Plant, and Equipment, have been added back to Adjusted
EBITDA.
Xerium (NYSE:XRM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Xerium (NYSE:XRM)
Historical Stock Chart
From Oct 2023 to Oct 2024